Virologic and biochemical responses to clevudine in patients with chronic HBV infection-associated cirrhosis: data at week 48.
about
KASL clinical practice guidelines: management of chronic hepatitis BA comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B.A comparison of clevudine and entecavir for treatment-naïve patients with chronic hepatitis B: results after 2 years of treatment.
P2860
Virologic and biochemical responses to clevudine in patients with chronic HBV infection-associated cirrhosis: data at week 48.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@ast
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@en
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@nl
type
label
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@ast
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@en
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@nl
prefLabel
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@ast
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@en
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@nl
P2093
P2860
P1476
Virologic and biochemical resp ...... ed cirrhosis: data at week 48.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2893.2010.01304.X
P577
2011-04-01T00:00:00Z